| 1 | Study | 1.83% | |
| 2 | Lymphoma | 1.83% | |
| 3 | Control | 0.92% | |
| 4 | Reduced | 0.92% | |
| 5 | Offers | 0.92% | |
| 6 | Factors | 0.92% | |
| 7 | Titers | 0.92% | |
| 8 | Gut | 0.92% | |
| 9 | Central | 0.92% | |
| 10 | Speckle-Tracking | 0.92% | |
| 11 | Pump | 0.92% | |
| 12 | Detection | 0.92% | |
| 13 | Antibody | 0.92% | |
| 14 | Patient | 0.92% | |
| 15 | Indicator | 0.92% | |
| 16 | Inhibitor | 0.92% | |
| 17 | Rapid | 0.92% | |
| 18 | Overlap | 0.92% | |
| 19 | Complexity | 0.92% | |
| 20 | Comorbidities | 0.92% | |
| 21 | Therapy | 0.92% | |
| 22 | Elderly | 0.92% | |
| 23 | Antimuscarinic | 0.92% | |
| 24 | Multiple | 0.92% | |
| 25 | FFMI | 0.92% | |
| 26 | Multimodal | 0.92% | |
| 27 | Fracture | 0.92% | |
| 28 | Patients | 0.92% | |
| 29 | Ultra-Sensitive | 0.92% | |
| 30 | Targeting | 0.92% | |
| 31 | Diabetes | 0.92% | |
| 32 | Assay | 0.92% | |
| 33 | Metabolites | 0.92% | |
| 34 | Recognizing | 0.92% | |
| 35 | Acetylcholine | 0.92% | |
| 36 | Receptor | 0.92% | |
| 37 | Association | 0.92% | |
| 38 | Blindness | 0.92% | |
| 39 | Motsoaledi | 0.92% | |
| 40 | Sleep | 0.92% | |
| 41 | Pulse | 0.92% | |
| 42 | Interventions | 0.92% | |
| 43 | Activity | 0.92% | |
| 44 | Virus | 0.92% | |
| 45 | Subclinical | 0.92% | |
| 46 | Askin | 0.92% | |
| 47 | Left | 0.92% | |
| 48 | Presentation | 0.92% | |
| 49 | Dysfunction | 0.92% | |
| 50 | Mellitus | 0.92% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||